U.S. Household Products Stock News

CACI International (NYSE:CACI) has announced and priced a $500 million senior notes offering. The company plans to use the proceeds to help fund its acquisition of ARKA Group L.P. The transaction affects CACI International's capital structure and future debt obligations. For investors watching NYSE:CACI, this new senior notes offering comes at a time when the stock is trading at $629.75. The shares show longer term returns of 78.4% over the past year, 110.5% over three years, and 182.1%...

If you are wondering whether Palantir Technologies' current share price still makes sense after everything that has happened with the stock, this article will walk you through what the current market price could be implying about its value. The stock closed at US$147.22, with returns of 9.7% over the last 7 days, a 0.4% decline over 30 days, a 12.3% decline year to date, 63.3% over 1 year, and a very large gain over 3 years, which naturally raises questions about how much optimism is already...

Conference appearance puts U.S. Gold in focus U.S. Gold (USAU) is set to present at the Emerging Growth Virtual Conference on February 25, 2026. Executive Chairman Luke Anthony Norman is expected to speak, drawing attention to potential commentary on projects and capital needs. See our latest analysis for U.S. Gold. At a share price of US$18.84, U.S. Gold has seen a 7 day share price return of 4.96% and a 30 day share price return of 8.65%. The 1 year total shareholder return of 125.90% and 3...

Agios Pharmaceuticals recently announced that the Emirates Drug Establishment in the UAE approved PYRUKYND (mitapivat) as the first and only medicine for adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia. This approval, supported by global Phase 3 ENERGIZE and ENERGIZE-T data and backed by a regional partnership with NewBridge Pharmaceuticals, strengthens Agios’s push into Gulf markets for rare blood disorder treatments. Next, we’ll examine...

If you are wondering whether Ross Stores is still good value after its run in the market, it helps to separate the share price story from what the underlying business may be worth. The stock last closed at US$197.64, with a 1.5% decline over 7 days, a 4.8% gain over 30 days, and returns of 8.2% year to date, 47.0% over 1 year, 85.9% over 3 years, and 67.2% over 5 years. This naturally raises questions about what is already priced in. Recent coverage around Ross Stores has largely focused on...

Axos Financial (AX) has been in focus after higher than expected inflation data raised doubts about near term rate cuts, putting pressure on bank stocks and sharpening investor attention on interest rate risk. See our latest analysis for Axos Financial. Despite the inflation driven sell off that recently hit Axos Financial, the current US$89.97 share price sits above its 90 day level, and the 1 year and 3 year total shareholder returns of 39.92% and 97.82% suggest momentum has been positive...

Why Twilio’s latest earnings and KPN partnership are drawing fresh attention Twilio (TWLO) is back on investors’ radar after fourth quarter results came in ahead of guidance, organic revenue growth impressed analysts, and fresh Buy ratings followed, helped by expanding AI focused products and the new RCS partnership with KPN Netherlands. See our latest analysis for Twilio. At a share price of $123.51, Twilio has seen an 8.48% 7 day share price return but a 10.73% decline year to date. The 1...

Aflac stock after recent performance Aflac (AFL) has been relatively steady in recent trading, with a 1-day return of about a 0.8% decline and a flat move over the past week, keeping investors focused on its longer-term record. See our latest analysis for Aflac. At a share price of US$112.43, Aflac’s recent pullback sits against a firmer backdrop, with a 30 day share price return of 1.33% and a 5 year total shareholder return of 151.14%. This suggests sentiment has been supportive over time...

Harry Potter tie-in puts McCormick’s Butterbeer flavors in focus McCormick (MKC) is back in the spotlight after partnering with Warner Bros. Discovery to launch limited edition Harry Potter Butterbeer Finishing Sugar and Butterbeer Flavor across major retailers. The collaboration gives investors a fresh data point on how licensing deals and themed products might influence McCormick’s broad consumer portfolio, which already spans spices, sauces, seasonings, and dessert products worldwide. See...

AbbVie recently reported positive topline Phase 3 results from its AFFIRM trial, showing risankizumab (SKYRIZI) subcutaneous induction led to significantly higher clinical remission and endoscopic response rates than placebo in adults with moderately to severely active Crohn’s disease, with safety consistent with prior data. Because AFFIRM included patients who had already failed multiple advanced therapies, the results highlight SKYRIZI’s potential to address a difficult-to-treat Crohn’s...

The Morning Bull - US Market Morning Update Wednesday, Mar, 4 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts down about 0.2%, as investors juggle stubborn inflation worries and mixed global growth signals. The US 10 year Treasury yield is holding near 4.06%, which indicates borrowing costs remain relatively high and keeps pressure on areas like real estate and smaller, debt heavy companies. At the same time, a large 5.6 million barrel build in US oil...

What Medline’s recent fundamentals mean for investors Medline (MDLN) has drawn fresh attention after investors focused on its latest reported fundamentals, including US$28.4b in revenue, US$1.2b in net income, and single digit annual growth rates across both measures. See our latest analysis for Medline. Despite US$28.4b of revenue and US$1.2b of net income drawing focus to fundamentals, Medline’s recent 1-day share price return of a 3.18% decline and 7-day share price return of an 11.2%...

In February 2026, Peoples Group announced a major partnership with Fiserv to power its next-generation Canadian payments infrastructure using Fiserv’s Enterprise Payments Platform and DNA core in the public cloud, supporting instant payments, always-on connectivity, and ISO 20022 data ahead of Payments Canada’s Real-Time Rail rollout. This represents one of Peoples Group’s largest technology investments and highlights how Fiserv’s cloud-based payments stack is increasingly becoming a...

If you are wondering whether Intuitive Surgical's current share price still reflects good value, you are not alone; many investors are asking the same question before making their next move. The stock last closed at US$497.42, with returns of 0.7% over 7 days, a 1.3% decline over 30 days, an 11.5% decline year to date and a 10.9% decline over 1 year, set against gains of 115.6% over 3 years and 112.3% over 5 years. Recent attention on Intuitive Surgical has centred on its position in robotic...

Cavco Industries triggered stock overview Cavco Industries (CVCO) has drawn investor attention after recent share price moves, with the stock up about 15% over the past month while the past 3 months show a modest decline. See our latest analysis for Cavco Industries. While Cavco’s 30 day share price return of 14.5% stands out, year to date share price performance is softer, and the longer term total shareholder returns of 8.5% over 1 year and 154.3% over 5 years show a very different...

AMETEK (AME) is in focus after reporting Q4 2025 earnings and revenue above forecasts, lifting its 2026 outlook, outlining a $100 million growth investment, and announcing a dividend increase that caught investors’ attention. See our latest analysis for AMETEK. Despite a 2.6% one day share price decline and a flat week, AMETEK’s 5.0% 30 day and 18.1% 90 day share price returns, alongside a 1 year total shareholder return of 29.2%, suggest momentum has recently been building. If this update...

GXO Logistics (NYSE:GXO) has entered a new partnership with lingerie retailer Hunkemoller to manage its B2B logistics. The agreement covers operations at a state of the art facility in Almere and is structured as a multi year deal. This is Hunkemoller’s first time outsourcing its B2B logistics operations to an external provider. For you as an investor, this move highlights how GXO Logistics (NYSE:GXO) positions itself as a specialist in complex, tech driven logistics for retailers. The...

Agnico Eagle Mines (NYSE:AEM) is back on investors’ radar after a run of strong quarterly earnings beats and rising earnings estimates, which has coincided with solid recent share price gains. See our latest analysis for Agnico Eagle Mines. At a share price of $234.52, Agnico Eagle Mines has seen strong momentum recently, with a 30-day share price return of 23.11% and a year to date share price return of 37.59%. Its 1-year total shareholder return of 147.14% and very large 3-year and 5-year...

NextDecade (NasdaqCM:NEXT) approved positive final investment decisions on Trains 4 and 5 at its Rio Grande LNG Facility. The company executed multiple long term LNG sale and purchase agreements tied to these additional trains. These steps expand NextDecade's planned LNG production capacity and build out its contracted commercial portfolio. NextDecade focuses on developing LNG export capacity at its Rio Grande LNG Facility, positioning itself as a US Gulf Coast supplier to global buyers...

Rumors are circulating that Sanofi is considering a significantly higher acquisition bid for Ocular Therapeutix (NasdaqGM:OCUL). The speculation follows recent regulatory developments that may create new or faster FDA approval routes for the company’s ophthalmology programs. Market attention has increased as investors assess what a larger potential offer and altered commercialization timelines could mean for OCUL’s valuation and future role in eye care. Ocular Therapeutix focuses on...

Kyndryl Holdings, Inc. recently reported a past quarter where revenue grew but missed analyst expectations and EPS fell short, even as it expanded AI, cloud, and security offerings, launched a Cyber Defense Operations Center in India, and advanced healthcare AI collaborations in the UK. These developments highlight Kyndryl’s push into integrated AI, cybersecurity, and digital sustainability services, even as weaker earnings raised questions about how quickly that shift can translate into...

In the past week, insurance software provider Guidewire Software announced a multi-year partnership with Sompo Group to roll out its cloud platform globally, received board approval for a share repurchase program, and prepared to report earnings following a quarter that beat revenue expectations but missed billings estimates. Together, the Sompo collaboration, upcoming earnings release, and new buyback authorization highlight how Guidewire is trying to deepen insurer relationships while...

What recent returns say about Marathon Petroleum stock Recent trading in Marathon Petroleum (MPC) has caught investor attention, with the shares showing positive moves over the past week, month, and past 3 months, as well as on a 1 year and multi year basis. Against that backdrop, it is worth looking at how the company’s current valuation metrics, profitability, and business mix across refining, midstream, and renewable diesel compare with the recent share performance. See our latest analysis...

In late February 2026, Arista Networks reported strong fourth-quarter results and lifted its full-year growth outlook and AI revenue forecast to US$3.25 billion, largely driven by accelerating demand from Cloud and AI customers. This shift means AI-related networking could contribute about 30% of Arista’s total revenue this year, with up to four customers each accounting for more than 10% of sales, underscoring both the scale of demand and the concentration of its client base. With Arista...